| Recommendations | Dated |
| IVIg Utilization Management Program Recommendations | Jul 2019 |
| Note: The above recommendations are under revision and do not reflect current practice. Provincial panel screening of SCIG for Neurology and Rheumatology conditions took effect on April 1, 2025. Follow links for further information on Immunology recommendations for SID and Neurology recommendations for CNS and PNS. | |
| TMS Ig Request Process | Dated |
| Ig Request Process | Feb 2025 |
| Note: Provincial panel screening of SCIG for Neurology and Rheumatology conditions took effect on April 1, 2025. | |
| Ig Screening Request Form | |
| Outcome Questionnaire | |
| IVIg - PNS | SCIg - PNS |
| IVIg - CNS | SCIg - CNS |
| IVIg - Rheumatology | SCIg - Rheumatology |
|
For all provincially screened adult Rheumatology or Neurology cases, refer to the screening request form and outcome questionnaire as listed above. Please note there are minor differences between each form for IVIg and SCIg, due to differences in dosing. |
|
